Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | SI | P14410 | 1/20 | 0.35 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1230797 | 0.96 | MGAM (0.35) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL1230743 | 0.96 | MGAM (0.35) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL1230604 | 0.88 | MGAM (0.44) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL5153206 | 0.86 | MGAM (0.39) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL5149525 | 0.85 | MGAM (0.38) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL1361662 | 0.84 | MGAM (0.34) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL1361274 | 0.81 | MGAM (0.32) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL1362311 | 0.81 | MGAM (0.32) | MGAMGAASIMGAM2TSHR | |
| Acetaldehyde SCHEMBL6053469 | 0.78 | MGAM (0.35) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL13947740 | 0.77 | LMNA (0.41) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1746134-B1 | CURABLE COMPOSITION WITH IMPROVED CURABILITY AND ADHESIVENESS | KANEKA CORP (JP) | 2019-09-04 | — | — | EP | disclosed |
| EP-1746135-B1 | CURABLE COMPOSITION | KANEKA CORP (JP) | 2019-05-29 | — | — | EP | disclosed |
| US-7973108-B2 | Curable composition | KANEKA CORPORATION (JP) | 2011-07-05 | — | — | US | disclosed |
| US-7910681-B2 | Curable composition having improved adhesion | KANEKA CORPORATION (JP) | 2011-03-22 | — | — | US | disclosed |
| US-7893170-B2 | Curable composition having improved curability and adhesion | KANEKA CORPORATION (JP) | 2011-02-22 | — | — | US | disclosed |
| US-20080319152-A1 | Curable Composition | KANEKA CORPORATION (JP) | 2008-12-25 | — | — | US | disclosed |
| US-20080194773-A1 | Polysiloxane from silanetriol group, a titanium, aluminum or a zirconium catalyst, and a low molecular weight compound containing a hydrolyzable silicon group; sealants, adhesives | KANEKA CORPORATION (JP) | 2008-08-14 | — | — | US | disclosed |
| US-20080076878-A1 | Organic polymer having a silane tiol group, a titanium, aluminum or a zirconium catalyst, and a low molecular weight compound containing a hydrolyzable silicon group; sealants, adhesives | KANEKA CORPORATION (JP) | 2008-03-27 | — | — | US | disclosed |
| EP-1746133-A1 | CURABLE COMPOSITION IMPROVED IN ADHESIVENESS | Kaneka Corporation (JP) | 2007-01-24 | — | — | EP | disclosed |
| EP-1746135-A1 | CURABLE COMPOSITION | Kaneka Corporation (JP) | 2007-01-24 | — | — | EP | disclosed |
| EP-1746134-A1 | CURABLE COMPOSITION WITH IMPROVED CURABILITY AND ADHESIVENESS | Kaneka Corporation (JP) | 2007-01-24 | — | — | EP | disclosed |